GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Helix BioPharma Corp (TSX:HBP) » Definitions » PB Ratio

Helix BioPharma (TSX:HBP) PB Ratio : (As of May. 26, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Helix BioPharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-26), Helix BioPharma's share price is C$0.205. Helix BioPharma's Book Value per Share for the quarter that ended in Jan. 2024 was C$-0.00. Hence, Helix BioPharma's PB Ratio of today is .

The historical rank and industry rank for Helix BioPharma's PB Ratio or its related term are showing as below:

During the past 13 years, Helix BioPharma's highest PB Ratio was 25.27. The lowest was 1.83. And the median was 9.57.

TSX:HBP's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.5
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Helix BioPharma's average Book Value Per Share Growth Rate was -109.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Helix BioPharma was 12.60% per year. The lowest was -35.10% per year. And the median was -15.55% per year.

Back to Basics: PB Ratio


Helix BioPharma PB Ratio Historical Data

The historical data trend for Helix BioPharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Helix BioPharma PB Ratio Chart

Helix BioPharma Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 30.00 - 95.00 -

Helix BioPharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.00 41.00 - 73.33 -

Competitive Comparison of Helix BioPharma's PB Ratio

For the Biotechnology subindustry, Helix BioPharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Helix BioPharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Helix BioPharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Helix BioPharma's PB Ratio falls into.



Helix BioPharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Helix BioPharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jan. 2024)
=0.205/-0.001
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Helix BioPharma  (TSX:HBP) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Helix BioPharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Helix BioPharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Helix BioPharma (TSX:HBP) Business Description

Traded in Other Exchanges
Address
401 Bay Street, Suite 2704, Toronto, ON, CAN, M5H 2Y
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.